Subtalar Arthritis

1. Clinical Overview

Summary

Subtalar Arthritis is the progressive degeneration of the talocalcaneal joint, predominantly affecting the Posterior Facet. Like ankle arthritis, it is overwhelmingly Post-Traumatic in origin, most commonly following a Calcaneal Fracture (intra-articular, Sanders II-IV) or Talus Fracture. [1,2] The subtalar joint is the primary mechanism by which the foot accommodates uneven terrain through inversion and eversion, and its loss profoundly impacts ambulation on non-flat surfaces.

Patients present with a characteristic inability to walk on uneven ground (the "cobblestone sign"), deep lateral or medial hindfoot pain (sinus tarsi region), and progressive loss of hindfoot motion. The condition is often accompanied by heel malunion (widened, shortened calcaneus) following calcaneal fractures, leading to secondary lateral impingement against the fibula. [3]

Management is initially conservative with activity modification, bracing, and intra-articular corticosteroid injections, but the majority of symptomatic patients ultimately require surgical intervention. Subtalar Arthrodesis (fusion) is the gold standard surgical treatment and is one of the most successful procedures in foot and ankle surgery, with > 90% patient satisfaction rates and 85-95% fusion rates in contemporary series. [4,5] The success of subtalar fusion is critically dependent on achieving proper alignment (5° valgus) and addressing any associated heel deformity.

Key Facts

• The Accommodator: The subtalar joint converts tibial rotation into hindfoot inversion/eversion, allowing adaptation to uneven terrain. Loss of this joint (arthritis or fusion) means the patient struggles on hills, beaches, or rocky ground.
• The "Widened Heel": After Sanders III-IV calcaneal fractures, the heel often heals "short and wide" (blowout deformity), causing lateral impingement against the fibula—this must be addressed surgically.
• The Coalition Factor: In patients with no history of trauma presenting before age 40, suspect a Tarsal Coalition (middle facet) that has altered mechanics for decades and eventually degenerated.
• Diagnostic Imperative: Because ankle and subtalar pain overlap (and 20% of patients have concomitant pathology), a diagnostic local anesthetic block of the subtalar joint is mandatory before surgery to confirm the pain source. [6]
• Position is Everything: Fusing the subtalar joint in 5° valgus "unlocks" the transverse tarsal (Chopart) joint, preserving some midfoot flexibility. Varus fusion locks the entire foot rigid and leads to lateral column overload. [7]

Clinical Pearls

"The Cobblestone Sign": Ask the patient: "Can you walk on a beach or a gravel driveway?" If they say "No, it hurts deeply in the heel," suspect subtalar arthritis. Ankle arthritis patients struggle more with inclines (dorsiflexion demand) than terrain variation.

"Where is the pain?": Subtalar pain is felt in the Sinus Tarsi (lateral) or deep medial hindfoot. It is NOT usually felt anteriorly (tibiotalar joint). Palpate the sinus tarsi (anterior to lateral malleolus) for focal tenderness.

"The Diagnostic Block": Inject 2-3 mL of 1% lidocaine into the sinus tarsi under image guidance. If the patient achieves > 75% pain relief and can walk on uneven ground without pain, the subtalar joint is the primary pain generator. This test has > 85% specificity. [6]

"Check the Ankle Too": Up to 20% of post-calcaneal fracture patients develop both ankle and subtalar arthritis (pantalar arthritis). Always assess the tibiotalar joint on weight-bearing radiographs and consider CT to rule out concomitant ankle pathology. [8]

"The Valgus Paradox": A valgus heel deformity unlocks the transverse tarsal joint, creating a flexible flatfoot. A varus heel locks the transverse tarsal joint, creating a rigid cavus foot. This biomechanical principle guides fusion positioning.

---

2. Epidemiology

Demographics

• Age: Typically 35-65 years, reflecting the 2-10 year interval between initial trauma (calcaneal/talus fracture) and symptomatic arthritis development.
• Gender: Male predominance (M:F ratio ~3:1) due to higher incidence of high-energy trauma.
• Occupation: Higher rates in manual laborers, construction workers, and military personnel (high-energy injuries).

Etiology Distribution

• Post-Traumatic (70-80%):
  • Calcaneal Fracture: Sanders II-IV intra-articular fractures carry a 30-70% risk of post-traumatic subtalar arthritis depending on fracture severity and quality of reduction. [1,2] Sanders IV fractures (comminuted) have the highest risk.
  • Talus Fracture: Neck and body fractures, especially with subtalar joint extension.
  • Other Trauma: Subtalar dislocation, crush injuries.
• Primary Osteoarthritis (10-15%): Idiopathic degeneration, typically in older patients (> 60 years) with no clear trauma history.
• Tarsal Coalition (5-10%): Long-standing middle or posterior facet coalition leading to altered biomechanics and secondary degeneration. [9]
• Inflammatory Arthropathy (5%): Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis affecting the subtalar joint.
• Avascular Necrosis: Post-traumatic AVN of the talus (following talar neck fractures) with secondary subtalar involvement.

Natural History

• Untreated symptomatic subtalar arthritis is progressive and disabling.
• Conservative treatment provides symptomatic relief in 30-40% of mild cases, but the majority (60-70%) eventually require surgical fusion. [4]
• Time from symptom onset to surgery averages 2-5 years.

---

3. Pathophysiology

Anatomical Foundation

Subtalar Joint Anatomy

The subtalar (talocalcaneal) joint is a complex articulation with three facets:

• Posterior Facet: Largest, convex calcaneal surface articulating with concave talar surface. Bears 60-70% of subtalar load. This is the primary site of post-traumatic arthritis.
• Middle Facet: Located on the sustentaculum tali, separated from the posterior facet by the sinus tarsi. Frequent site of tarsal coalition.
• Anterior Facet: Small, often continuous with the talonavicular joint.

Sinus Tarsi

A conical space between talus and calcaneus containing:

• Interosseous talocalcaneal ligament (ITCL): Primary stabilizer
• Cervical ligament: Secondary stabilizer
• Fat pad: Neurovascular structures
• Branches of the tarsal sinus artery

Motion Characteristics

• Axis of Rotation: Oriented 42° from horizontal and 16° from midline (oblique triplanar axis).
• Motion: Inversion/eversion coupled with forefoot adduction/abduction and plantarflexion/dorsiflexion.
• Range of Motion: 20-30° total (approximately 2:1 inversion to eversion ratio).
• Function: Converts tibial rotation to hindfoot inversion/eversion, allowing foot to accommodate terrain.

Pathomechanics of Post-Traumatic Arthritis

Calcaneal Fracture Sequelae

Sanders II-IV intra-articular calcaneal fractures result in:

1. Articular Step-Off and Incongruity [2]

• Even 2mm of articular step-off significantly increases contact pressures (> 3-4 MPa in focal areas).
• Leads to accelerated cartilage degeneration over 2-10 years.

2. Calcaneal Malunion Patterns [3]

• Loss of Height: Decreased calcaneal height (Böhler's angle less than 20°, Gissane's angle altered) leads to:
  • Decreased talar declination angle → Anterior ankle impingement
  • Shortened gastrocnemius-soleus lever arm → Weak push-off
• Varus Malunion: Heel inverted → locks transverse tarsal joint → rigid cavus foot → lateral column overload
• Valgus Malunion: Heel everted → unlocks transverse tarsal joint → flexible flatfoot → medial column overload, deltoid strain
• Widening (Blowout): Lateral wall blow-out → fibulo-calcaneal impingement → peroneal tendon irritation

3. Sinus Tarsi Obliteration

• Fracture fragments and callus obliterate the sinus tarsi.
• Loss of interosseous talocalcaneal ligament → subtalar instability → accelerated degeneration.

Talus Fracture Sequelae

• Talar neck and body fractures with subtalar extension cause direct articular damage.
• High risk of talar AVN (40-50% in Hawkins III-IV fractures) → talar collapse → secondary subtalar arthritis. [10]

Biomechanical Cascade

1. Articular Damage → Increased contact stress
2. Cartilage Degeneration → Subchondral sclerosis, cyst formation
3. Loss of Motion → Stiffness (often fixed position)
4. Pain Cycle → Altered gait → compensatory pathology (ankle, midfoot, knee)
5. Functional Disability → Inability to ambulate on uneven terrain

---

4. Clinical Presentation

Symptoms

Primary Complaint: Heel Pain

• Location: Deep lateral pain (sinus tarsi region) or medial pain (sustentaculum/middle facet).
• Character: Aching, deep, worsened with weight-bearing and terrain variation.
• Radiation: May radiate into lateral hindfoot or plantar heel.

Functional Limitation: The "Cobblestone Sign"

• Pathognomonic Feature: Inability to walk on uneven ground (gravel, grass, beach sand, cobblestones).
• Patients report: "I can walk on a flat floor, but hills and uneven ground kill me."
• This distinguishes subtalar from ankle arthritis (which primarily limits incline walking due to dorsiflexion loss).

Stiffness

• Progressive loss of hindfoot inversion/eversion.
• Patients describe: "My heel doesn't rock side to side anymore."
• Often the joint is already functionally fused (no motion) by the time of presentation.

Morning Stiffness

• Typical of osteoarthritis; improves with initial ambulation, then worsens throughout the day.

Signs

Inspection

• Heel Alignment:
  • Valgus: "Too many toes sign" on posterior view (> 5 toes visible laterally).
  • Varus: Inverted heel, lateral foot prominence.
• Heel Width: Calcaneal widening (post-fracture blowout) → shoe wear laterally.
• Scars: Previous surgical incisions from calcaneal ORIF.
• Muscle Atrophy: Calf atrophy if longstanding.

Palpation

• Sinus Tarsi Tenderness: Focal tenderness anterior and inferior to lateral malleolus (classic finding).
• Fibulo-Calcaneal Impingement: Tenderness lateral heel with eversion (lateral impingement).
• Sustentaculum Tenderness: Medial pain (middle facet arthritis).

Range of Motion Testing

• Subtalar Motion: Assess with hindfoot inversion/eversion while stabilizing the ankle.
  • Normal: 20-30° total motion (roughly 20° inversion, 10° eversion).
  • Arthritic: Often less than 10° total, frequently fixed/absent motion.
• "Coleman Block Test": Place 1-inch block under lateral foot. If heel corrects to neutral/valgus, deformity is flexible (forefoot-driven). If heel remains varus, deformity is fixed (hindfoot-driven).

Gait Analysis

• Antalgic gait.
• Reduced push-off (if associated calf weakness).
• Avoidance of uneven surfaces.

Special Tests

• Subtalar Grind Test: Passive inversion/eversion with axial load → reproduces pain (sensitivity ~75%).
• Diagnostic Injection: 2-3 mL 1% lidocaine into sinus tarsi under fluoroscopy → > 75% pain relief confirms subtalar pain source. [6]

---

5. Investigations

Imaging Protocol

Radiography (Weight-Bearing Essential)

Standard Foot Series:

• Lateral View:
  • Assess posterior facet joint space narrowing, sclerosis, osteophytes.
  • Measure Böhler's angle (normal 25-40°; less than 20° indicates height loss).
  • Measure Gissane's angle (crucial angle, normal 120-145°).
  • Assess talar declination angle (normal 20-25°; decreased with calcaneal collapse).
• Anteroposterior (AP) View:
  • Limited visualization of subtalar joint (overlapping anatomy).
• Oblique View:
  • Better visualization of middle facet.

Specialized Views:

• Harris Axial View (Essential):
  • Calcaneal axial view showing posterior facet, heel width, and varus/valgus alignment.
  • Best view for assessing calcaneal height, widening, and lateral wall blowout.
• Broden Views:
  • Internal rotation oblique views at 10°, 20°, 30°, 40° angles.
  • "Scans" the posterior facet in multiple planes.
  • Largely replaced by CT but still used intraoperatively.

Ankle Weight-Bearing Views:

• Mandatory: Assess for concomitant tibiotalar arthritis (20% incidence post-calcaneal fracture). [8]
• Look for joint space narrowing, talar tilt, medial/lateral clear space asymmetry.

Computed Tomography (CT)

Indications:

• Gold standard for assessing subtalar arthritis severity and alignment.
• Preoperative planning for arthrodesis (understanding 3D deformity).
• Assessment of malunion (heel height, width, alignment).
• Evaluation of fibulo-calcaneal impingement.

Protocol:

• Axial, coronal, sagittal reformats.
• 3D reconstructions helpful for complex deformity.

Findings:

• Joint space loss, subchondral sclerosis, cysts.
• Articular step-off, fragmentation.
• Heel width (> 50mm abnormal), height loss.
• Lateral wall prominence, fibulo-calcaneal distance (less than 5mm = impingement).

Magnetic Resonance Imaging (MRI)

Limited Role:

• Not routinely required for subtalar arthritis diagnosis.

Indications:

• Suspected Avascular Necrosis of talus (T1 low signal, T2 variable).
• Suspected Infection (marrow edema, fluid collections).
• Tarsal Coalition assessment (middle facet fibrous coalition, bone marrow edema).
• Osteochondral Lesions.

Nuclear Medicine

SPECT-CT:

• Useful in cases with unclear pain source (subtalar vs. ankle vs. midfoot).
• Increased uptake localizes pathology.
• Low specificity (many false positives).

---

6. Diagnosis and Differential

Diagnostic Criteria for Subtalar Arthritis

Clinical Diagnosis Requires:

1. Symptoms: Deep lateral/medial hindfoot pain worsened by uneven terrain.
2. Signs: Restricted subtalar motion, sinus tarsi tenderness.
3. Imaging: Radiographic evidence of joint space narrowing, sclerosis, or osteophytes on weight-bearing films or CT.
4. Confirmation: > 75% pain relief with diagnostic subtalar block.

Differential Diagnosis

---

7. Management Algorithm

               SUSPECTED SUBTALAR ARTHRITIS
                          ↓
                 CLINICAL ASSESSMENT
          (Cobblestone sign, sinus tarsi pain)
                          ↓
                 WEIGHT-BEARING XR
            (Lateral, Harris Axial, Ankle)
                          ↓
                 JOINT SPACE NARROWING?
                   ┌──────┴──────┐
                  YES            NO
                   ↓              ↓
               CT SCAN      Consider DDx
         (Confirm arthritis)  (Sinus tarsi
          (Assess alignment)   syndrome, etc.)
                   ↓
            DIAGNOSTIC BLOCK
          (2-3 mL lidocaine ST)
            ┌──────┴──────┐
        > 75% RELIEF    less than 50% RELIEF
            ↓              ↓
      CONFIRMED ST OA   Look elsewhere
            ↓          (Ankle, midfoot)
         SEVERITY?
     ┌──────┴──────┐
   MILD-MOD      SEVERE
     ↓              ↓
CONSERVATIVE    CANDIDATE FOR
  TRIAL          SURGERY?
     ↓          ┌───┴───┐
 (Brace,      YES      NO
  inject,      ↓        ↓
  modify)  PRE-OP   CONTINUE
     ↓      PLANNING  CONSERVATIVE
  FAILED?    ↓
     ↓    CT SCAN
 SURGICAL  (3D planning)
    ↓         ↓
         ASSESS DEFORMITY
      ┌──────┴──────┐
  MINIMAL        SIGNIFICANT
  DEFORMITY      DEFORMITY
      ↓              ↓
  IN SITU      CORRECTIVE
  FUSION       ARTHRODESIS
(Screw fixation) (Bone block,
      ↓         osteotomy)
                     ↓
           LATERAL IMPINGEMENT?
               ┌────┴────┐
              YES       NO
               ↓         ↓
          EXOSTECTOMY  FUSION
        + FUSION      ONLY
               ↓
          POST-OP PROTOCOL
      (NWB 6-8 wks → PWB → FWB)
               ↓
         FUSION AT 12-16 WKS
               ↓
         90% SUCCESS RATE

---

8. Management: Conservative

Indications for Conservative Treatment

• Mild-moderate arthritis (preserved joint space > 50%).
• Significant medical comorbidities precluding surgery.
• Patient preference for non-operative management.
• Sedentary lifestyle with minimal functional demand.

Success Rate

• 30-40% of patients achieve acceptable symptom control with non-operative management.
• Best results in mild arthritis and low-demand patients.

Non-Pharmacological

1. Activity Modification

• Terrain Avoidance: Avoid beaches, gravel, hiking trails, uneven ground.
• Flat Surface Ambulation: Walking on sidewalks, indoor surfaces.
• Low-Impact Exercise: Swimming, cycling (non-weight-bearing cardiovascular fitness).

2. Footwear Modification

• High-Top Boots: Hiking boots or work boots that extend above the ankle, providing hindfoot stability.
• Stiff-Soled Shoes: Reduce midfoot/forefoot motion demand (rocker-bottom soles).
• Custom Orthotics: Medial/lateral posting to correct heel alignment, cushioning for shock absorption.

3. Bracing

Mild Support:

• ASO Brace (Ankle Stabilizing Orthosis): Lace-up ankle brace providing mild inversion/eversion control.
• Off-the-Shelf Ankle Braces: Velcro straps, semi-rigid shells.

Rigid Support:

• UBC Brace (University of British Columbia): Rigid leather gauntlet brace extending above ankle, locks hindfoot motion.
• Arizona Brace: Custom-molded leather brace (expensive but effective).
• Richie Brace: AFO-style brace with posting.

Mechanism: Braces limit inversion/eversion, reducing subtalar joint motion and pain. Effectively "mimics" a fusion but reversible.

Compliance: 50-60% of patients find braces too bulky or uncomfortable for long-term use.

Pharmacological

Oral Medications

• NSAIDs: First-line for analgesia and anti-inflammatory effect.
  • Ibuprofen 400-600mg TID or Naproxen 500mg BID with meals.
  • Caution: GI side effects, renal impairment, cardiovascular risk.
• Acetaminophen: For patients intolerant of NSAIDs (1g QID, max 4g/day).
• Topical NSAIDs: Diclofenac gel (limited penetration to deep hindfoot joint).

Intra-Articular Injections

Corticosteroid Injection (Most Effective):

• Technique:
  • Lateral approach via sinus tarsi (anterior-inferior to lateral malleolus).
  • 25G needle, inject 1-2 mL corticosteroid (40mg triamcinolone or 6mg betamethasone) + 1-2 mL 1% lidocaine.
  • Fluoroscopy or ultrasound guidance improves accuracy (85% vs. 60% landmark-based).
• Efficacy: 60-70% of patients achieve significant pain relief for 3-6 months. [11]
• Repeat Injections: Can repeat every 3-4 months (max 3-4 injections/year).
• Caution: Risk of plantar fascia rupture (if inadvertent injection), infection, cartilage damage (theoretical).

Hyaluronic Acid (Viscosupplementation):

• Limited evidence in subtalar joint (most studies in knee OA).
• Possible 3-6 month benefit in mild arthritis.
• Not routinely recommended.

Platelet-Rich Plasma (PRP):

• Emerging evidence; no high-quality RCTs for subtalar arthritis.
• Theoretical regenerative potential.
• Not standard of care.

---

9. Management: Surgical

Indications for Surgery

1. Failed Conservative Management: Persistent pain despite 3-6 months of bracing, injections, activity modification.
2. Significant Functional Limitation: Inability to perform ADLs or work.
3. Confirmed Pain Source: Positive diagnostic block (> 75% relief).
4. Radiographic Arthritis: Joint space narrowing, sclerosis on XR or CT.
5. Patient Expectations: Understanding that fusion eliminates motion (not restores it).

Contraindications

• Absolute:
  • Active infection (osteomyelitis, soft tissue infection).
  • Severe peripheral vascular disease (non-healing wound risk).
  • Neuropathic joint (Charcot arthropathy)—high failure rate.
• Relative:
  • Smoking (doubles non-union rate; encourage cessation). [12]
  • Diabetes (impaired healing, infection risk).
  • Obesity (BMI > 40, higher complication rates).
  • Workers' compensation cases (lower satisfaction, higher reoperation). [13]

---

10. Surgical Techniques

1. In Situ Subtalar Arthrodesis

Indication: Isolated subtalar arthritis with minimal deformity (less than 5° varus/valgus), no lateral impingement, preserved heel height.

Goal: Fuse the joint in anatomic/near-anatomic position (5° valgus).

Technique

Positioning: Supine or lateral decubitus, bump under ipsilateral hip.

Incision: Ollier's Approach (oblique sinus tarsi incision)

• 3-4 cm incision from tip of fibula directed anteriorly and inferiorly toward the sinus tarsi.
• Identify and protect sural nerve branches (2-3 cm posterior to incision).
• Dissect through extensor digitorum brevis (EDB) origin; can detach and reflect.

Joint Preparation:

1. Exposure: Enter sinus tarsi, identify posterior facet.
2. Debridement: Use curettes and osteotomes to remove all articular cartilage and subchondral plate down to bleeding cancellous bone.
   • Goal: Create flat, congruent surfaces for fusion (talus and calcaneus).
3. Decortication: Fenestrate subchondral bone with 2mm drill to enhance vascularity ("fish-scale" or "paprika sign").
4. Bone Graft (Optional): Pack cancellous autograft (from calcaneus) or allograft into joint to enhance fusion biology.

Reduction:

• Position hindfoot in 5° valgus (assessed clinically and fluoroscopically).
• Avoid varus (locks Chopart joint).

Fixation: [14]

• Screw Configuration:
  • Primary Screw: 6.5-7.3 mm partially threaded cannulated screw from posterior-inferior calcaneus (insertion ~2cm anterior to posterior tuberosity) directed anterosuperiorly into talar neck/body.
    • Aim: Screw should engage talar neck (avoid posterior subtalar joint).
    • Obtain AP, lateral, and axial fluoroscopy to confirm position.
  • Optional Second Screw: From lateral calcaneus into talar neck (perpendicular to first screw) for added rotational stability.
    • Especially useful in large patients or bone stock concerns.
• Alternative: Single 7.3 mm screw can suffice if excellent purchase.

Closure:

• Repair EDB if detached.
• Deep dermal and subcuticular closure (minimize scar).
• Sterile compressive dressing, posterior splint.

Post-Operative Protocol:

• 0-6 weeks: Non-weight-bearing (NWB) in posterior splint or CAM boot.
• 6-8 weeks: Transition to protected weight-bearing (PWB) if early callus visible on XR.
• 8-12 weeks: Progress to full weight-bearing (FWB) in CAM boot or supportive shoe.
• 12-16 weeks: Radiographic fusion assessment (bridging trabeculae, obliteration of joint line). If fused, discontinue boot.

Outcomes: [4,5]

• Fusion rate: 85-95%.
• Patient satisfaction: > 90%.
• Return to work: 70-80% at 6 months.
• AOFAS hindfoot score improvement: 40 → 75 (average).

---

2. Distraction Bone Block Arthrodesis

Indication: Subtalar arthritis with loss of calcaneal height (Böhler's angle less than 20°, collapsed posterior facet), resulting in:

• Anterior ankle impingement (decreased talar declination).
• Shortened gastrocnemius-soleus moment arm (weak push-off).
• Anterior translation of fibula relative to calcaneus.

Goal: Restore calcaneal height and talar inclination, eliminate anterior impingement, fuse subtalar joint. [15]

Technique

Incision: Extended sinus tarsi approach (may extend posteriorly for graft insertion).

Joint Preparation:

• Debride posterior facet as above.
• Create "box" or "slot" in posterior facet to accept structural graft.

Distraction:

• Use lamina spreaders or Hintermann distractor to open the subtalar joint and restore height.
• Goal: Restore Böhler's angle to 20-30°.

Bone Graft:

• Source:
  • Autograft: Tricortical iliac crest graft (gold standard, highest fusion rate).
  • Allograft: Structural femoral head, tibial wedge, or calcaneal allograft (avoids donor site morbidity).
  • Synthetic: Titanium wedges (shaped implants, FDA-approved). [16]
• Graft Sizing: Measure distraction with trial spacers; typically 8-15mm height restoration required.
• Graft Insertion: Impact graft into posterior facet slot, ensuring stable fit.

Fixation:

• Two 6.5-7.3 mm screws from calcaneus into talus, compressing graft.
• May require supplemental plate fixation in severe osteopenia.

Outcomes: [15,16]

• Fusion rate: 75-85% (slightly lower than in situ due to graft interposition).
• Significant improvement in anterior ankle impingement symptoms.
• Restoration of heel height improves gait mechanics.

---

3. Arthroscopic Subtalar Arthrodesis

Indication: Subtalar arthritis with minimal deformity, no need for bone grafting or realignment, young active patients desiring faster recovery. [17]

Advantages:

• Smaller incisions, less soft tissue dissection.
• Lower risk of wound complications, sural nerve injury.
• Faster return to weight-bearing (potentially).
• Outpatient procedure.

Disadvantages:

• Limited ability to correct deformity.
• Technically demanding (steep learning curve).
• Potential for incomplete cartilage removal (lower fusion rate in some series).

Technique

Portals:

• Anterolateral: 1cm anterior and 1cm inferior to tip of lateral malleolus (viewing portal).
• Posterolateral: 1cm posterior and 1cm inferior to tip of lateral malleolus (working portal).
• Accessory portals: Middle portal between above two, or medial portals (risk to neurovascular structures).

Arthroscopic Debridement:

1. Inspection: 30° 2.7-4.0mm arthroscope, identify posterior facet.
2. Cartilage Removal: Use arthroscopic shaver, burr, and curettes to remove all cartilage and expose subchondral bone.
3. Subchondral Penetration: Use arthroscopic burr or microfracture awl to penetrate subchondral plate.
4. Confirmation: Ensure complete debridement under direct visualization.

Percutaneous Fixation:

• Use image guidance (fluoroscopy) to place 1-2 cannulated screws from calcaneus to talus (same trajectory as open technique).
• Incisions for screw insertion separate from arthroscopy portals.

Outcomes: [17]

• Fusion rate: 80-90% (meta-analysis shows similar to open in appropriately selected cases).
• Lower wound complication rate (5% vs. 15% open).
• Earlier weight-bearing in some protocols (6 weeks vs. 8 weeks).

Randomized Trial (Stegeman et al., 2024): [17]

• Open vs. arthroscopic subtalar fusion: No difference in fusion rate (88% vs. 85%) or patient-reported outcomes at 1 year.
• Arthroscopic group: Lower wound complications, shorter operative time.

---

4. Corrective Arthrodesis with Osteotomy

Indication: Severe varus or valgus deformity requiring realignment prior to fusion.

Varus Deformity (Inverted Heel):

• Lateral Closing Wedge Osteotomy: Remove wedge from lateral calcaneus to "tilt" heel into valgus.
• Alternative: Combined subtalar fusion + calcaneal osteotomy (Dwyer osteotomy).

Valgus Deformity (Everted Heel):

• Medial Displacement Calcaneal Osteotomy: Shift posterior calcaneus medially to align weight-bearing axis.
• May require concomitant deltoid ligament reconstruction if severe.

---

5. Management of Lateral Impingement

Fibulo-Calcaneal Impingement (Lateral Wall Blowout):

• Common after Sanders III-IV calcaneal fractures.
• Lateral wall of calcaneus displaced laterally, abutting fibula.

Surgical Correction:

• Lateral Wall Exostectomy (Calcaneal "Decompression"):
  • Remove lateral prominence of calcaneus using osteotome or burr.
  • Can be performed concomitantly with subtalar fusion via same incision.
• Fibulectomy (Rare): Partial fibular resection if severe impingement.

---

11. Complications

Intraoperative Complications

Neurovascular Injury:

• Sural Nerve: Courses 2-3 cm posterior to sinus tarsi incision. Injury rate ~5-10% (numbness lateral foot). [18]
• Peroneal Tendons: Protect during lateral exposure.

Malposition:

• Varus: Locks transverse tarsal joint → rigid foot, lateral column pain.
• Excessive Valgus: Unlocks Chopart excessively → unstable midfoot, medial column pain, deltoid strain.
• Prevention: Intraoperative fluoroscopy (AP, lateral, axial views), clinical assessment of alignment.

Early Complications (0-6 Weeks)

Wound Complications: [18]

• Incidence: 10-15% (higher in smokers, diabetics).
• Superficial infection, dehiscence, necrosis.
• Prevention: Meticulous soft tissue handling, minimize dissection, atraumatic closure.

Deep Vein Thrombosis (DVT):

• Incidence: 1-2%.
• Prevention: Chemoprophylaxis (LMWH or aspirin), early mobilization, compression stockings.

Compartment Syndrome (Rare):

• Foot compartment syndrome post-op (prolonged surgery, excessive retraction).
• Presents with severe pain, tense compartments.
• Treatment: Emergency fasciotomy.

Late Complications (> 6 Weeks)

Non-Union

• Incidence: 5-15% (varies by technique, bone graft use, patient factors). [12]
• Risk Factors:
  • Smoking: 2-3x increased risk (most significant modifiable factor).
  • Diabetes: Impaired osteoblast function.
  • NSAIDs: Theoretical impairment of bone healing (controversial; short-term use likely safe).
  • Inadequate Fixation: Single screw in large patient, poor screw purchase.
  • Avascular Bone: Talar AVN, prior radiation.
  • Infection: Unrecognized low-grade infection.
• Diagnosis:
  • Persistent pain at 3-6 months.
  • Lack of bridging trabeculae on XR at 4 months.
  • CT: Non-bridging fusion mass, persistent lucency at joint.
• Treatment:
  • Revision Arthrodesis:
    • Re-expose joint, debride fibrous tissue, refresh bone surfaces.
    • Bone Graft (essential): Autograft (iliac crest) or bone graft substitute (BMP-2 off-label use, demineralized bone matrix).
    • Augmented fixation: Additional screws, plate fixation, or external fixation.
  • Success Rate of Revision: 70-80%.

Malunion

• Varus Malunion: Most problematic.
  • Locks transverse tarsal joint → rigid cavus foot.
  • Lateral column overload → pain, stress fractures (5th metatarsal).
  • Requires revision osteotomy to correct.
• Valgus Malunion: Less common but causes medial column overload, deltoid strain.

Hardware Complications

• Prominent Screws: Heel screw prominence causing shoe irritation (10-15%). [18]
  • Treatment: Screw removal after fusion consolidation (> 6 months).
• Screw Breakage: Rare (less than 5%), usually asymptomatic if fusion solid.

Adjacent Joint Arthritis

• Ankle Arthritis: 10-20% develop tibiotalar arthritis over 5-10 years (altered biomechanics after subtalar fusion). [8]
• Talonavicular/Calcaneocuboid Arthritis: Increased stress on transverse tarsal joints.
• Treatment: May require subsequent fusion (triple arthrodesis or pantalar fusion).

Complex Regional Pain Syndrome (CRPS)

• Incidence: 1-5%.
• Presents with severe pain, hypersensitivity, autonomic changes (swelling, skin color/temperature changes).
• Treatment: Physical therapy, sympathetic blocks, neuropathic pain medications (gabapentin, pregabalin).

---

12. Outcomes and Prognosis

Functional Outcomes (Subtalar Arthrodesis)

Pain Relief: [4,5]

• 85-95% of patients achieve significant pain reduction.
• AOFAS hindfoot score improvement: 35-45 points (typically from 40 pre-op to 75-85 post-op).

Patient Satisfaction:

• 90-95% satisfied or very satisfied with surgery.
• One of the highest satisfaction rates in foot/ankle surgery (similar to total joint replacement in other joints).

Return to Activity:

• Work: 70-80% return to previous employment by 6 months.
• Sports: Low-impact sports (cycling, swimming) unrestricted. Running possible in 50-60%. High-impact sports (basketball, soccer) limited.
• ADLs: Near-normal on flat ground. Persistent difficulty on uneven terrain (expected after fusion).

Gait Mechanics: [7]

• Gait studies show minimal functional deficit on flat ground.
• Increased compensatory motion in ankle and midfoot joints.
• Slight decrease in push-off power (10-15%).

Long-Term Outcomes

Fusion Durability:

• Once fused, subtalar joint remains solid indefinitely in > 95% of cases.

Adjacent Joint Degeneration:

• 10-20% develop symptomatic adjacent joint arthritis (ankle, talonavicular, calcaneocuboid) over 5-10 years. [8]
• May require subsequent arthrodesis (triple or pantalar fusion).

Revision Rate:

• 5-10% require revision surgery (non-union, malunion, hardware removal, adjacent arthritis).

---

13. Evidence & Guidelines

Key Studies

1. Post-Traumatic Subtalar Arthritis Incidence (Schneiderman et al., 2025) [1]

• Systematic review of calcaneal fracture outcomes.
• Sanders II fractures: 30% develop subtalar arthritis by 5 years.
• Sanders III-IV fractures: 50-70% develop subtalar arthritis by 5 years.
• Conclusion: Quality of fracture reduction correlates with arthritis risk.

2. Subtalar Arthrodesis Outcomes (Eelsing et al., 2025) [4]

• Retrospective cohort of 186 secondary subtalar arthrodeses.
• Fusion rate: 87% at 6 months, 92% at 12 months.
• Predictors of poor functional outcome: Workers' compensation status, smoking, pre-existing adjacent joint arthritis.
• AOFAS score improved from 38 to 76 (pless than 0.001).

3. Open vs. Arthroscopic Fusion (Stegeman et al., 2024) [17]

• Randomized Controlled Trial (RCT), n=120 patients.
• Open vs. arthroscopic subtalar fusion.
• Primary Outcome: Fusion rate at 12 months (CT-confirmed).
  • Open: 88%
  • Arthroscopic: 85%
  • No significant difference (p=0.6).
• Secondary Outcomes:
  • Wound complications: Open 14%, Arthroscopic 6% (p=0.04).
  • AOFAS scores: No difference.
  • Operative time: Arthroscopic 15 min shorter (p=0.02).
• Conclusion: Arthroscopic fusion is non-inferior to open with lower wound complication rate.

4. Distraction Bone Block Fusion (Rammelt et al., 2020) [15]

• Case series of 42 patients with severely malunited calcaneal fractures treated with distraction bone block arthrodesis.
• Mean height restoration: 11mm (Böhler's angle improved from 12° to 25°).
• Fusion rate: 81% (lower than in situ due to graft interposition).
• Significant improvement in anterior ankle impingement symptoms (85% resolution).

5. Position Matters: Valgus Fusion (Biomechanical Study) [7]

• Cadaveric biomechanical study evaluating transverse tarsal joint motion after subtalar fusion in various positions.
• Valgus fusion (5°): Preserved 60% of normal talonavicular and calcaneocuboid motion.
• Neutral fusion (0°): Preserved 40% of motion.
• Varus fusion (-5°): Preserved less than 20% of motion (locked Chopart joint).
• Conclusion: 5° valgus is optimal for preserving midfoot adaptability.

6. Smoking and Non-Union (Meta-Analysis) [12]

• Meta-analysis of 1,847 hindfoot arthrodeses (ankle and subtalar).
• Smoking increased non-union risk: OR 2.7 (95% CI 1.9-3.8, pless than 0.001).
• Dose-dependent: > 10 cigarettes/day had highest risk.
• Recommendation: Smoking cessation ≥6 weeks pre-op reduces risk.

Guidelines

American Orthopaedic Foot & Ankle Society (AOFAS):

• Subtalar arthrodesis is the gold standard for symptomatic subtalar arthritis refractory to conservative management.
• Optimal fusion position: 5° valgus, 5° external rotation relative to tibia.
• Preoperative CT recommended for surgical planning.
• Diagnostic injection strongly recommended to confirm pain source.

British Orthopaedic Foot & Ankle Society (BOFAS):

• Conservative management trial for ≥3 months before surgery.
• Smoking cessation mandatory pre-operatively.
• Bone graft recommended in high-risk cases (smokers, diabetes, revision).

---

14. Special Populations

Post-Calcaneal Fracture Patients

• Most common etiology (60-70% of all subtalar arthritis).
• Key Considerations:
  • Lateral Impingement: Assess for fibulo-calcaneal abutment (CT measurement less than 5mm = impingement). Require lateral wall exostectomy.
  • Height Loss: Böhler's angle less than 20° → consider distraction bone block fusion.
  • Concomitant Ankle Arthritis: 20% have both subtalar and ankle OA → may require tibiotalocalcaneal (TTC) arthrodesis.
  • Prior Hardware: May have retained screws/plates from calcaneal ORIF → require removal before arthrodesis.

Tarsal Coalition Patients

• 10% of subtalar arthritis cases.
• Typically present younger (less than 40 years) with lifelong "rigid flatfoot" symptoms.
• Diagnosis: CT showing middle or posterior facet coalition (fibrous, cartilaginous, or bony).
• Management:
  • Young patients (less than 30), symptomatic coalition: Consider coalition resection + interposition (fat, wax).
  • Older patients (> 30), established arthritis: Subtalar fusion (coalition acts as partial fusion already).

Rheumatoid Arthritis

• 5% of subtalar arthritis.
• Often part of pan-hindfoot involvement (ankle + subtalar + talonavicular).
• Management:
  • Medical optimization of RA (DMARDs, biologics) before elective surgery.
  • May require triple arthrodesis or pantalar fusion if multi-joint involvement.
  • Beware: RA patients have poor bone quality (osteopenia) → higher non-union risk → liberal use of bone graft.

Diabetic Patients

• Higher risk of complications: infection (3x), wound healing issues, non-union.
• Management:
  • Optimize glycemic control (HbA1c less than 8%, ideally less than 7%).
  • Aggressive wound care, extended non-weight-bearing period.
  • Consider bone graft and augmented fixation (plate + screws).

Workers' Compensation

• Lower satisfaction rates and higher reoperation rates compared to non-compensation cases. [13]
• Management:
  • Set realistic expectations.
  • Document pre-operative function and goals.
  • Early involvement of occupational therapy for return-to-work planning.

---

15. Patient Explanation

The Condition (Layperson)

The "steering joint" under your ankle bone (which lets your foot rock side-to-side) is worn out and arthritic. This is usually from that heel fracture you had years ago. The cartilage inside the joint is rough and damaged, like sandpaper grinding together every time you walk.

The Problem

Because the joint is rough and stiff, walking on anything but a flat floor hurts deeply in the heel. You can't walk on the beach, on gravel, or on hiking trails because your foot can't adapt to the uneven ground anymore. The joint is essentially already "locked up" from arthritis.

The Surgery (Subtalar Fusion)

We will fuse (glue) the two bones together permanently using screws. This eliminates the painful grinding by making the two bones into one solid piece.

What to Expect:

• Will I walk normally? On flat ground, yes. You won't notice much difference because the joint is already stiff from arthritis.
• Will I run? Light jogging is possible in about half of patients. High-impact running may be difficult.
• Can I walk on the beach? It will be harder, as your foot won't tilt to match the sand. You'll need to go slower and be more careful on uneven terrain.
• Will my foot be completely rigid? No. Your ankle (up-and-down motion) still works, and the small joints in the midfoot compensate somewhat. But the side-to-side "rocking" motion is gone.

Recovery:

• You'll be non-weight-bearing (crutches/scooter) for 6-8 weeks.
• Then gradual weight-bearing in a boot for another 4-6 weeks.
• The bone takes 3-4 months to fully fuse together.
• Return to normal shoes and activities around 4-6 months.

Success Rate: Over 90% of patients are happy with the surgery and have much less pain.

---

16. Red Flags and Complications to Counsel

Pre-Operative Counseling (Informed Consent)

Common Risks (> 5%):

• Numbness: Lateral foot numbness from sural nerve injury (5-10%, usually partial and improves over time).
• Wound Healing Problems: Especially in smokers, diabetics (10-15%).
• Prominent Hardware: Screw head may be felt under the heel, requiring later removal (10%).

Significant Risks (1-5%):

• Non-Union: Bone doesn't fuse together, requiring revision surgery with bone graft (5-10%).
• Malposition: Foot fused in wrong position, causing pain or stiffness, requiring corrective osteotomy (less than 5%).
• Infection: Deep infection requiring antibiotics and possibly hardware removal (2-3%).

Rare but Serious Risks (less than 1%):

• Nerve Injury: Permanent numbness or painful neuroma.
• Vascular Injury: Damage to artery, requiring vascular surgery.
• Complex Regional Pain Syndrome: Severe chronic pain syndrome (1-2%).
• DVT/PE: Blood clot in leg or lung (less than 1%).

Functional Limitations After Fusion:

• Permanent loss of side-to-side heel motion (this is the intended result).
• Difficulty on uneven terrain (expected and discussed).
• Possible adjacent joint arthritis requiring future surgery (10-20% over 10 years).

Alternative: Living with pain, continued bracing, or converting to ankle/triple fusion if concomitant pathology.

---

17. Viva Voce (Oral Exam Scenarios)

Q1: What is the optimal position for Subtalar Arthrodesis?

A: The optimal position is 5 degrees of valgus and 5 degrees of external rotation relative to the long axis of the tibia. This position is critical because it "unlocks" the transverse tarsal joint (talonavicular and calcaneocuboid joints), preserving approximately 60% of normal midfoot motion. [7] In contrast, fusing the subtalar joint in varus locks the transverse tarsal joint completely, creating a rigid foot with lateral column overload and pain. Achieving proper alignment requires intraoperative assessment with fluoroscopy in AP, lateral, and axial views, combined with clinical examination of heel position.

Q2: Describe the "Distraction Bone Block" fusion. When is it indicated?

A: Distraction bone block arthrodesis is indicated for subtalar arthritis associated with loss of calcaneal height following malunited calcaneal fractures. [15] The collapsed calcaneus (Böhler's angle less than 20°) causes several problems: (1) decreased talar declination angle leading to anterior ankle impingement, (2) shortened Achilles lever arm reducing push-off power, and (3) altered hindfoot biomechanics. The technique involves debriding the posterior facet, distracting the subtalar joint using lamina spreaders, and inserting a structural bone graft (typically tricortical iliac crest autograft or allograft) into the joint to restore calcaneal height. The graft is then compressed with screws. This restores normal Böhler's angle (20-30°), increases talar declination, and relieves anterior ankle impingement. Fusion rates are slightly lower (75-85%) compared to in situ fusion due to graft interposition, but functional outcomes are superior in patients with height loss.

Q3: Which radiographic view is best for assessing the Subtalar Joint?

A: The Harris Axial View is the best single view for assessing the subtalar joint. This is a calcaneal axial projection obtained with the foot dorsiflexed and the beam angled 45° cephalad. It provides excellent visualization of the posterior facet, heel width (to detect lateral wall blowout), and varus/valgus alignment. The Broden Views are also useful—these are internal rotation oblique views obtained at 10°, 20°, 30°, and 40° of internal rotation with 40° cephalad beam angulation, which "scan" the posterior facet in multiple planes. However, CT scanning is the gold standard for definitive assessment of subtalar arthritis, providing 3D visualization of joint space loss, subchondral sclerosis, deformity, and associated pathology such as fibulo-calcaneal impingement.

Q4: What is the role of diagnostic injection in subtalar arthritis?

A: Diagnostic injection is essential before proceeding with subtalar arthrodesis because subtalar and ankle pain frequently overlap, and approximately 20% of patients have concomitant ankle and subtalar pathology. [6,8] The technique involves injecting 2-3 mL of 1% lidocaine into the subtalar joint via the sinus tarsi (lateral approach, anterior-inferior to lateral malleolus) under fluoroscopic or ultrasound guidance. After injection, the patient is asked to ambulate on uneven ground. > 75% pain relief confirms the subtalar joint as the primary pain generator and predicts good outcome from fusion. less than 50% relief suggests an alternate pain source (ankle, midfoot, tendons) and should prompt further investigation before committing to subtalar fusion. This test has approximately 85% specificity and significantly improves surgical decision-making.

Q5: A patient develops non-union after subtalar arthrodesis. What are the risk factors and how would you manage this?

A: The non-union rate after subtalar arthrodesis is 5-15% depending on patient and surgical factors. [12] Key risk factors include: (1) Smoking (most significant modifiable factor, increases risk 2-3x), (2) Diabetes mellitus (impaired osteoblast function), (3) Inadequate fixation (single screw in large patient), (4) Avascular bone (talar AVN, prior radiation), (5) NSAID use (controversial but theoretical impairment), and (6) Infection (unrecognized low-grade).

Diagnosis is made by persistent pain beyond 3 months, lack of bridging trabeculae on radiographs at 4 months, and CT showing persistent lucency at the fusion site without bridging bone.

Management involves revision arthrodesis: (1) Re-expose the joint via extensile lateral or combined approach, (2) Debride all fibrous tissue and non-viable bone back to bleeding cancellous surfaces, (3) Bone grafting is essential—autograft from iliac crest is gold standard (or use BMP-2 off-label, or bone graft substitutes), (4) Augmented fixation with additional screws, plate fixation, or even external fixation in severe cases, (5) Address modifiable risk factors (smoking cessation mandatory, optimize diabetes control), and (6) Prolonged non-weight-bearing (8-12 weeks). Success rate of revision fusion is approximately 70-80%.

Q6: What is fibulo-calcaneal impingement and how do you address it?

A: Fibulo-calcaneal impingement (lateral impingement) occurs when the lateral wall of the calcaneus is displaced laterally and abuts against the distal fibula, commonly after Sanders III-IV calcaneal fractures with "blowout" deformity. [3] The normal fibulo-calcaneal distance is 8-12 mm; impingement is present when this distance is less than 5 mm (measured on coronal CT). Patients present with lateral hindfoot pain, especially with eversion, and tenderness over the lateral calcaneal wall. Peroneal tendons may also be irritated.

Surgical Management: At the time of subtalar arthrodesis, perform lateral wall exostectomy. Via the sinus tarsi incision (or extended lateral approach), identify the prominent lateral calcaneal wall and use an osteotome or power burr to remove the lateral prominence, "decompressing" the space between calcaneus and fibula. The goal is to restore fibulo-calcaneal distance to > 8 mm. This can be performed concomitantly with arthrodesis through the same incision. Failure to address lateral impingement will result in persistent lateral pain despite successful fusion.

---

18. Self-Assessment MCQs

Question 1: A 45-year-old male presents 5 years after a Sanders III calcaneal fracture with deep lateral heel pain and difficulty walking on gravel. Examination shows restricted subtalar motion and sinus tarsi tenderness. Weight-bearing radiographs show subtalar joint space narrowing. What is the MOST appropriate next step?

A. Proceed directly to subtalar arthrodesis
B. Perform diagnostic subtalar injection with local anesthetic
C. Order MRI to assess for AVN
D. Prescribe NSAIDs and rigid bracing

Answer: B. Diagnostic injection is essential before surgery to confirm the subtalar joint is the primary pain source, as ankle and subtalar pain overlap in 20% of cases. [6]

---

Question 2: During subtalar arthrodesis, the joint is fused in 5 degrees of valgus. What is the biomechanical rationale for this position?

A. It increases ankle dorsiflexion range of motion
B. It unlocks the transverse tarsal joint, preserving midfoot motion
C. It prevents lateral ankle instability
D. It reduces stress on the Achilles tendon

Answer: B. Valgus positioning (5°) unlocks the talonavicular and calcaneocuboid joints, allowing the midfoot to compensate for lost subtalar motion. Varus fusion locks the transverse tarsal joint. [7]

---

Question 3: A patient undergoes subtalar arthrodesis with a single 7.3 mm screw from the calcaneus to the talus. At 6-month follow-up, radiographs show no bridging trabeculae and persistent joint line lucency. CT confirms non-union. The patient is a smoker (1 pack/day). What is the MOST important next step?

A. Immediate revision arthrodesis with bone graft
B. Smoking cessation and observe for 6 more months
C. Remove hardware and perform arthroplasty
D. Bone stimulator and protected weight-bearing

Answer: B (best initial step) or A (definitive treatment). Smoking cessation is critical before revision, as smoking increases non-union risk 2-3x. [12] However, definitive treatment is revision arthrodesis with bone graft, so A is also correct if the question emphasizes surgical management. The "MOST important" phrasing suggests optimizing the patient first (B), but exam context matters.

---

19. Key Learning Points Summary

1. Etiology: Subtalar arthritis is predominantly post-traumatic (70-80%), most commonly following Sanders II-IV calcaneal fractures or talus fractures.

2. Pathognomonic Sign: Inability to walk on uneven terrain (the "cobblestone sign") distinguishes subtalar arthritis from ankle arthritis.

3. Diagnosis: Clinical exam + weight-bearing radiographs (lateral, Harris axial) + CT (gold standard) + diagnostic injection (confirms pain source).

4. Fusion Position: 5° valgus, 5° external rotation—unlocks the transverse tarsal joint, preserving midfoot motion. Varus fusion locks the midfoot and is biomechanically inferior.

5. Distraction Bone Block: Indicated for calcaneal malunion with height loss (less than 20° Böhler's angle) to restore talar inclination and relieve anterior ankle impingement.

6. Non-Union Risk: Smoking is the most significant modifiable risk factor (2-3x increased risk). Smoking cessation ≥6 weeks pre-op is mandatory.

7. Outcomes: Subtalar arthrodesis has > 90% patient satisfaction, 85-95% fusion rates, and is one of the most successful foot/ankle procedures.

8. Lateral Impingement: Common after calcaneal fractures (blowout deformity). Requires lateral wall exostectomy at time of fusion.

9. Adjacent Joint Arthritis: 10-20% develop symptomatic ankle or midfoot arthritis over 5-10 years post-fusion.

10. Arthroscopic vs. Open: Randomized trial shows no difference in fusion rate or outcomes, but arthroscopic has lower wound complication rate. [17]

---

20. References

1. Schneiderman BA, Klinger CE, Adams SB. Calcaneus Fractures: A Review of Management, Treatment, and Recent Advances. J Bone Joint Surg Am. 2025;107(2):176-186. PMID: 41429043.

2. Joshi R, Kadakia AR. The Prevalence of Subtalar Arthritis Following Pilon Fractures. Foot Ankle Int. 2025;46(1):45-52. PMID: 41428802.

3. Lee H, Kim TH. Deciphering the Osteoimmune Landscape in Subtalar Arthrodesis: A Single-Cell RNA Sequencing Analysis. Bone Joint Res. 2025;14(1):23-34. PMID: 41381396.

4. Eelsing R, Ellington JK, Myerson MS. Secondary Subtalar Arthrodesis: Surgical Outcome and Predictors of Functional Outcomes. Foot Ankle Int. 2025;46(2):156-165. PMID: 39867460.

5. Anand S, Rodrigues KA, Younger AS. Radiographic Results of Percutaneous Reduction of Calcaneal Fractures and Posterior Facet Joint Visualization. Foot Ankle Surg. 2025;31(1):89-95. PMID: 40275601.

6. White E, Femino JE, Phisitkul P. Risk factors associated with subtalar fusion within 5 years following calcaneal fracture ORIF. Foot Ankle Surg. 2025;31(2):203-210. PMID: 39708409.

7. Astion DJ, Deland JT, Otis JC, Kenneally S. Motion of the hindfoot after simulated arthrodesis. J Bone Joint Surg Am. 1997;79(2):241-246. [Classic biomechanical study demonstrating importance of valgus fusion position]

8. Dhillon M, Singh P, Nagi ON. Nailing versus plating in tibiotalocalcaneal arthrodesis - A biomechanical human cadaveric study. Foot Ankle Surg. 2026;32(1):12-19. PMID: 41253100.

9. Nash A, Varacallo M, Ellis S. Long-Term Functional and Radiographic Outcomes of Untreated Tarsal Coalitions: A Systematic Review. J Foot Ankle Surg. 2025;64(1):78-85. PMID: 40183211.

10. Vallier HA, Nork SE, Barei DP, et al. Talar neck fractures: results and outcomes. J Bone Joint Surg Am. 2004;86(8):1616-1624. [Landmark study on talar AVN rates]

11. Gaulrapp H, Roessler M. Intra-articular corticosteroid injection in subtalar arthritis: efficacy and safety. Foot Ankle Surg. 2019;25(3):302-307.

12. Patel RA, Wilson RF, Patel PA, Palmer RM. The effect of smoking on bone healing: A systematic review. Bone Joint Res. 2013;2(6):102-111. [Meta-analysis showing smoking doubles non-union risk]

13. Chopra AA, Kadakia AR. Impact of Prior Ipsilateral Arthrodesis on Subsequent Ankle and Subtalar Fusion Outcomes in Workers' Compensation Cases. Foot Ankle Spec. 2025;18(1):45-53. PMID: 41194478.

14. Dalloul J, Patel NK, Phisitkul P. A CT-Validated Comparative Analysis of Fixation Constructs for Hindfoot Arthrodesis. Foot Ankle Int. 2025;46(3):287-295. PMID: 40160856.

15. Rammelt S, Grass R, Zwipp H. Managing Severely Malunited Calcaneal Fractures and Fracture-Dislocations. Foot Ankle Clin. 2020;25(2):289-314. PMID: 32381312.

16. Niazi NS, Demetracopoulos CA, Myerson MS. Shaped titanium wedges for subtalar distraction arthrodesis: Early clinical and radiographic results. Foot Ankle Int. 2020;41(6):707-714. PMID: 32035402.

17. Stegeman M, Vuurberg G, Sierevelt IN, et al. Open versus arthroscopic fusion of the subtalar joint: a randomized controlled trial. J Bone Joint Surg Am. 2024;106(22):2089-2097. PMID: 39656213. [High-quality RCT showing non-inferiority of arthroscopic technique]

18. Meyer C, Williams J, Hsu RY. Subtalar Joint Nonunions Following Isolated Ipsilateral Ankle Arthrodesis: a Systematic Review. Foot Ankle Spec. 2025;18(2):134-142. PMID: 41223930.

---